We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Of 50 novel drugs approved by the FDA in 2021, 22 have undergone clinical trials at research sites in Poland. The attractiveness of the country and the proof of its developed landscape for ckubucak research has been getting more evident every year.
In this brochure we have outlined major information and key data on the clinical research potential in the country.
Would you like to discuss your clinical trials options in Poland? Reach out to our local team representative to learn more at poland@oct-clinicaltrials.com
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
